Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening
BACKGROUND The majority of Chlamydia trachomatis infections in women are asymptomatic,
but may give rise to pelvic inflammatory disease (PID) and tubal infertility. Screening …
but may give rise to pelvic inflammatory disease (PID) and tubal infertility. Screening …
Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy
Introduction Asthma, allergic rhinitis, atopic dermatitis, and food allergy affect approximately
20% of the global population. Few studies describe the burden of the totality of these …
20% of the global population. Few studies describe the burden of the totality of these …
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action
The treatment of chronic kidney disease (CKD) and of end-stage renal disease (ESRD)
imposes substantial societal costs. Expenditure is highest for renal replacement therapy (RRT), …
imposes substantial societal costs. Expenditure is highest for renal replacement therapy (RRT), …
[HTML][HTML] Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Background Neurological disorders are now the leading source of disability globally, and
ageing is increasing the burden of neurodegenerative disorders, including Parkinson's disease…
ageing is increasing the burden of neurodegenerative disorders, including Parkinson's disease…
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to …
…, F Pishgar, MJ Postma, F Pourmalek, M Qorbani… - JAMA …, 2018 - jamanetwork.com
Importance The increasing burden due to cancer and other noncommunicable diseases
poses a threat to human development, which has resulted in global political commitments …
poses a threat to human development, which has resulted in global political commitments …
mScarlet: a bright monomeric red fluorescent protein for cellular imaging
…, L Van Weeren, M Postma, KE Wiese, M Mastop… - Nature …, 2017 - nature.com
We report the engineering of mScarlet, a truly monomeric red fluorescent protein with record
brightness, quantum yield (70%) and fluorescence lifetime (3.9 ns). We developed mScarlet …
brightness, quantum yield (70%) and fluorescence lifetime (3.9 ns). We developed mScarlet …
Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016
Introduction Multiple myeloma (MM) is a plasma cell neoplasm with substantial morbidity and
mortality. A comprehensive description of the global burden of MM is needed to help direct …
mortality. A comprehensive description of the global burden of MM is needed to help direct …
[HTML][HTML] Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic …
Background Lower respiratory infections are a leading cause of morbidity and mortality around
the world. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016, …
the world. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016, …
The dynamic mean-field density functional method and its application to the mesoscopic dynamics of quenched block copolymer melts
…, BAC Van Vlimmeren, NM Maurits, M Postma… - The Journal of …, 1997 - pubs.aip.org
In this paper we discuss a new generalized time-dependent Ginzburg-Landau theory for the
numerical calculation of polymer phase separation kinetics in 3D. The thermodynamic …
numerical calculation of polymer phase separation kinetics in 3D. The thermodynamic …
[HTML][HTML] A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
Background It is unknown whether patients undergoing primary percutaneous coronary
intervention (PCI) benefit from genotype-guided selection of oral P2Y 12 inhibitors. Methods We …
intervention (PCI) benefit from genotype-guided selection of oral P2Y 12 inhibitors. Methods We …